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Here, we developed a cell deﬁned siRNA microarray (CDSM) for
human bone marrow stromal cells (hBMSCs) designed to control
the culture of cells inside the spot area without reducing the
efﬁciency of siRNA silencing, “Development of a cell-deﬁned siRNA
microarray for analysis of gene functionin human bone marrow
stromal cells” (Kim et al., 2016 [1]). First, we conﬁrmed that p65
protein inhibition efﬁciency was maintained when hBMSCs were
culture for 7 days on the siRNA spot, and siRNA spot activity
remained in spite of long term storage (10 days and 2 months).
Additionally, we conﬁrmed p65 protein inhibition in U2OS cells
after 48 h reverse transfection.
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factorshBMSCs and U2OS cells were cultured on the array and induced knockdown of
p65 by siRNA spotxperimental
featureshBMSCs were seeded on siRNA spot array and incubated for 10 min for cell
attachment and then unattached cells were removed. Cell-spots were incubated
for 2 days and 7 days to induce knock down by siRNA spot. This experiment was
performed for conﬁrmation of siRNA spot activity by reverse transfection time
and by storage period of siRNA spot array. U2OS cells were carried out by siRNA
reverse transfection for 2 days following with same process as hBMSCsata source
locationInstitut Pasteur Korea, IP-Korea, Seongnam-si, Republic of Koreaata accessibility Data is provided within the articleValue of the data
 This data shows that CDSM is a useful tool for image-based siRNA screening with cellular models.
 This data shows that the preservation of siRNA stability in CDSM offers opportunity for siRNA
screening.
 This data proves that CDSM technology can be applied to hBMSCs and U2OS cells to identify gene
functions.1. Data
We conﬁrmed p65 gene expression knock down persistence effect for 7 days on CDSM (ave. 43.3%)
(Fig. 1). We identiﬁed p65 protein inhibition effect, 65.4% (10 days) and 41.3% (2 months) (Fig. 2). We
veriﬁed signiﬁcant efﬁciency on p65 inhibition from CDSM in U2OS (Fig. 3).2. Experimental design, materials and methods
All experimental design, materials and methods were based on reported paper [1]2.1. hBMSCs and U2OS cells culture
hBMSCs, human bone marrow stromal cells, (Lonza, Basel, Switzerland) were cultured in MSC
basal medium (MSCBM; Lonza), supplemented with BMSC growth medium (MSCGM), an hBMSCs
SingleQuots kit (Lonza), 5% fetal bovine serum, 1% L-glutamine, and 0.1% GA-1000. U2OS cell cultures
were maintained at 37 °C in a humidiﬁed cell incubator with an atmosphere of 5% CO2, and the
culture medium was changed twice per week.
U2OS osteosarcoma cells, (ATCC, Manassas, VA, USA) were cultured in DMEM high-glucose
medium supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin in a
humidiﬁed atmosphere of 5% CO2at 37 °C.
Fig. 1. (A) Immunoﬂuorescence image of p65 siRNA knock down effect after reverse transfection for 7 days (n¼6 array spots)
in hBMSCs. (B) Quantitative analysis for p65 positive cells ratio and cell numbers of (A). The ﬁgure images were acquired by an
ImageXpress Ultra point scanning confocal microscope with an anti-p65 antibody. Blue: Draq5 for the nucleus, Green: ﬂuor-
escence-labeled antibody to p65 protein. Scramble siRNA was used control. Each error bar represents the mean7SD.
(**po0.01: statistical signiﬁcance comparison of scramble siRNA). Scale bar¼100 mm.
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3 mL of 20 mM siRNA, 3.75 mM as the ﬁnal concentration, (scramble, p65, Slug, NCAD siRNA as a
smart pool of four individual siRNAs per target; Dharmacon, Lafayette, CO, USA) was transferred to
the 384-well V-bottom plate (Greiner Bio-one, Monroe, NC, USA) containing 2 mL of dH2O and 2 mL of
0.6 M sucrose, 80 mM as the ﬁnal concentration, (Invitrogen, Carlsbad, CA, USA) diluted in Opti-MEM
(Gibco, Grand Island, NY, USA). 2 mL of RNAi-Max [Invitrogen] was added and then the solution was
mixed gently. The complexes were incubated for 20 min at room temperature after centrifugation
(1200 rpm, 30 s). 5 mL of 0.4% gelatin (diluted in dH2O, 0.13% ﬁnal concentration, Invitrogen) and 2 mL
of growth factor reduced phenol red-free matrigel (BD Biosciences, San Jose, CA, USA) were added and
centrifuged (1200 rpm, 30 s) after mixing gently by pipetting.
Fig. 2. The examination of siRNA activity from cell-deﬁned microarray by storage period in hBMSCs. (A) The immuno-
ﬂuorescence image of p65 siRNA knock down effect after cell deﬁned siRNA microarray stored for 10 days and 2 months at 4 °C
(n¼9 array spots, scale bar¼100 mm). (B) Quantitative analysis for p65 positive cells ratio of (A). The ﬁgure images were
acquired by an ImageXpress Ultra point scanning confocal microscope with an anti-p65 antibody. Blue: Draq5 for the nucleus,
Green: ﬂuorescence-labeled antibody to p65 protein. Scramble siRNA was used control. Each error bar represents the
mean7SD. (***po0.001: statistical signiﬁcance comparison of scramble siRNA, **po0.01: statistical signiﬁcance in compar-
ison between the p65siRNA condition of 10 days and 2 months).
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Fig. 3. Conﬁrmation of the silencing effects of siRNA by the CDSM in U2OS cells. (A) Immunoﬂuorescence image of p65
silencing by the CDSM. (B) Quantitative analysis of p65-positive cell ratios and nucleus numbers from (A) (n¼9 array spots,
scale bar¼100 mm). The ﬁgure images were acquired by an ImageXpress Ultra point scanning confocal microscope with an
anti-p65 antibody. Blue: Draq5 for detection of nuclei, green: ﬂuorescence-labeled antibody targeting p65 protein. Scramble
siRNA was used as a control. Bars and error bars represent means7SDs. ***po0.001: statistical signiﬁcance in comparison
with scramble siRNA. Scale bar¼100 mm.
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Three-dimensional (3D) hydrogel-coated slides (H; 2575.61 mm3; SCHOTT, Elmsford, NY,
USA) were held at room temperature for 30 min to 1 h before opening the packaging bag. The pre-
pared siRNA transfection solution was printed on the 3D hydrogel-coated slide using SMP9 stealth
pins (Telechem, Atlanta, GA, USA) in a high-throughput microarray printer (Genomic Solutions, Ann
Arbor, MI, USA) at 22–25 °C and 55–60% relative humidity. Printed spots were 250–350 mm in dia-
meter with a 700 mm spot-to-spot interval. The prepared CDSMs were dried in a desiccating chamber
overnight, packaged in airtight bags, and then stored at 4 °C until further use.
2.4. hBMSCs and U2OS preparation, culture on the CDSMs
hBMSCs and U2OS cells stored in liquid nitrogen (LN2) tank were thawed into T25 or T75 ﬂasks
and then cultured for 1 week to reach 70–80% conﬂuence. The prepared cells (2105 cells/4 mL/
slide) were detached with 0.05% trypsin-EDTA (Gibco) then seeded onto CDSMs which were removed
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ment was induced for 10 min, and unattached cells were removed by washing 3–5 times with fresh
hBMSCs and DMEM medium. The attached cells on the spot region were cultured 2 days and 7 days
for reverse transfection.
2.5. Immunoﬂuorescence staining
The immunoﬂuorescence staining of hBMSCs and U2OS cells on CDSMs was performed using
standardized methods. The cells were washed with 1phosphate-buffered saline (PBS) once and ﬁxed
with 4% (w/v) paraformaldehyde in 1 PBS for 10 min. Cells were then washed again with 1 PBS and
permeabilized with 0.001% Triton-X100 in 1 PBS for 10 min. Primary antibody targeting p65 (1:400
dilution; rabbit polyclonal; Santa Cruz Biotechnology, Dallas, TX, USA) were diluted with 10% goat serum
in 1 PBS and incubated for 1.5 h at room temperature. After washing three times with 1PBS, sec-
ondary goat anti-rabbit conjugated with Alexa 488 were diluted with 10% goat serum in 1PBS and
incubated for 1.5 h at room temperature. After washing three times with 1 PBS, 5 mM DRAQ5 (1:2000
in PBS; Biostatus, Leicestershire, UK) was added, and samples were incubated for 10 min to stain the
nuclei. After rinsing with 1 PBS, 2–3 drops of mounting solution (Dako, France) was added to the
CDSM, and the slides were covered with glass coverslips (2460 mm2; Marienfeld, Germany), ensuring
that there were no air bubbles. Slides were then dried for 1 h at room temperature. After ﬁxing with
mounting solution, the CDSMs were stored at 4 °C until image acquisition.
2.6. Image acquisition and analysis
Immunoﬂuorescence imaging was performed using an ImageXpress Ultra point scanning confocal
microscope (Molecular Devices, Sunnyvale, CA, USA) equipped with four solid-state lasers for
simultaneous excitation at 405, 488, 561, and 635 nm; a galvanometer for X scanning; and a stage for
Y scanning. Each cell spot was scanned at 10or 20magniﬁcation using a Nikon air immersion
objective lens with speciﬁc ﬁlter sets for Alexa488. The acquired images were analyzed with
MetaXpress software (Molecular Devices). Cell scoring parameters were also determined to evaluate
the proportion of ﬂuorescent-positive cells which was calculated according to the ﬂuorescence
intensity, nuclei numbers, and size. GraphPad Prism 5 software (GraphPad Software, La Jolla, CA, USA)
was used to determine statistical signiﬁcance for comparisons of two groups by one-way or two-way
analysis of variance (ANOVA) and the Bonferroni method. Differences with p values of less than 0.05
were considered statistically signiﬁcant.Acknowledgment
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